• share
• favorite_border

• share
• favorite_border

New Cleveland Clinic-led research shows commonly used COVID-19 anti-viral drugs Paxlovid (nirmatrelvir) and Lagevrio (molnupiravir) reduce risk of hospitalization and death in high-risk patients with mild disease, even with Omicron subvariants.

• share
• favorite_border

Tuberculosis is old—ancient even. The infectious bacterial disease that plagued Old Testament Israelites and took down pharaohs was eventually stunted by vaccinations, antibiotics, and public health measures like isolation, but it hasn’t been cured yet. More than a million people around the world still die from TB every year.

• share
• favorite_border

A three-year, $2.3 million grant to study post-pandemic eviction stress and mental health has been awarded to researchers from UTHealth Houston by the National Institute of Nursing Research, part of the National Institutes of Health.

• share
• favorite_border

• share
• favorite_border

During the COVID pandemic, U.S. states and territories created websites to share relevant public health information. But a new study finds the sites don’t meet accessibility standards.

• share
• favorite_border

Researchers at the Francis Crick Institute, the University of Cambridge, Imperial College London, the University of Liverpool, the University of Cape Town and UKHSA have uncovered a link between an antiviral drug for COVID-19 infections called molnupiravir and a pattern of mutations in the SARS-CoV-2 virus.

• share
• favorite_border

New research used engineered mice to compare SARS-COV-2 omicron subvariants and found one of them – BA.5 – was more virulent likely due to its ability to rapidly replicate early during infection.

• share
• favorite_border

Research conducted at Mount Sinai and Yale confirms long COVID is a biological disease by showing blood biomarkers that can predict who has it

• share
• favorite_border

A study has revealed new details about a key population of immune system cells critical to successful vaccination against the pandemic virus, SARS-CoV-2.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

In August 2023, Americans made nearly a million calls for help to the 211 emergency resources helpline, according to 211 Counts, a national tracking system in 36 states developed by the Brown School’s Health Communication Research Laboratory at Washington University in St. Louis.

• share
• favorite_border

As cities brace for a confluence of flu, COVID-19, pneumonia, and RSV infections this fall, the American Thoracic Society announced that five new health systems have partnered with the Society to improve vaccination rates.

• share
• favorite_border

Findings from a nationwide, multicenter study led by Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health suggest that patients with COVID-19 have less chance of developing post-COVID conditions — commonly known as long COVID — if they receive early treatment with plasma from convalescent (recovered) COVID patients that contain antibodies against SARS-CoV-2, the virus that causes COVID-19.

• share
• favorite_border

Cases of Prolonged Grief Disorder among people bereaved during the COVID-19 pandemic are likely to be significantly higher than pre-pandemic, indicates new research from Cardiff University and the University of Bristol.

• share
• favorite_border

Discovery from the lab of Youyang Zhao, PhD, from Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago offers promising treatment approaches for acute respiratory distress syndrome (ARDS) in the elderly that can be caused by severe COVID-19, pneumonia, flu or sepsis.

• share
• favorite_border

One in three people exposed to SARS-CoV2 is infected, and as many as two in five with the Omicron variant. In the case of immunity — conferred by vaccination, infection or a combination of the two — this rate drops to one in ten.

• share
• favorite_border

Customers showing up even when they were sick, not agreeing with the restrictions, and many new tasks for staff. These are factors that contributed to heavier workloads and tougher work environments in pharmacies during the pandemic, a study reveals.

• share
• favorite_border

In a new study, researchers analyze the world’s largest social media platform and its efforts to remove Covid-19 vaccine misinformation during the pandemic.

• share
• favorite_border

A social media campaign launched in 2022 helped encourage some Nigerians to roll up their sleeves for a COVID vaccine, according to a study published today in PLOS ONE.

• share
• favorite_border

• share
• favorite_border

People who bought firearms during the height of the COVID-19 pandemic have much higher rates of recent suicidal thoughts, self-harm behaviors, and intimate partner violence, a new study suggests, compared with other firearm owners and people who do not own firearms.

• share
• favorite_border

A late summer increase in COVID-19-related hospitalizations and the emergence of new coronavirus variants raises concerns about how best to counter infection and who should receive the newly-approved vaccines.

• share
• favorite_border

A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no symptomatic or clinical benefit to taking the antidepressant fluvoxamine at a dosage of 100 mg twice daily for 13 days for the treatment of mild-to-moderate COVID-19 symptoms.

• share
• favorite_border

New UC Riverside research has revealed COVID’s Achilles heel — its dependence on key human proteins for its replication — which can be used to prevent the virus from making people sick.

• share
• favorite_border

High performance computing resources, advanced epidemiological models, and powerful algorithms will make dealing with future crises much easier, thanks to research led by Argonne National Laboratory.

• share
• favorite_border

It still feels like summer outside, but it’s time to prepare for the 2023-24 flu season.

• share
• favorite_border

The Department of Energy’s Office of Science has selected three Oak Ridge National Laboratory research teams to receive funding through DOE’s new Biopreparedness Research Virtual Environment, or BRaVE, initiative. BRaVE, announced earlier this year, aims to build on biopreparedness research that delivered high-impact results in the fight against COVID-19.

• share
• favorite_border

Researchers with the Department of Energy’s SLAC National Accelerator Laboratory and other institutions have been awarded $12 million in funding to help accelerate society’s response to emerging pathogens by improving X-ray science technology and processes.

• share
• favorite_border

Older adults who have had cancer had a high risk of experiencing symptoms of depression during the early months of the COVID-19 pandemic according to a new study published in Cancer Management and Research.

• share
• favorite_border

El Paso's journey began in March 2020 with its first confirmed case of COVID-19. By fall 2020, the city became the nation’s hotspot.